Source link : https://newshealth.biz/health-news/higher-dose-semaglutide-injection-proves-mettle-in-phase-iii-trials/
(MedPage Today) — Tripling the weekly dose of semaglutide (Ozempic, Wegovy) resulted in greater weight loss compared with placebo in adults with obesity, both with and without type 2 diabetes, but did not increase the risk of serious adverse events… Source link : https://www.medpagetoday.com/endocrinology/obesity/117466 Author : Publish date : 2025-09-15 18:15:00 Copyright for syndicated content […]
The post Higher-Dose Semaglutide Injection Proves Mettle in Phase III Trials first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-15 18:15:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8